Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,326 | -32,885 | -41,685 | -24,838 | -8,072 |
| Depreciation Amortization | 481 | 2,187 | 1,682 | 2,282 | 1,152 |
| Income taxes - deferred | 43 | 1,602 | -2,264 | -2,471 | N/A |
| Accounts receivable | -315 | -988 | -3,658 | -4,480 | -3,573 |
| Accounts payable and accrued liabilities | -2,690 | -5,502 | -6,505 | 1,064 | 522 |
| Other Working Capital | -6,207 | -4,479 | -561 | 4,523 | -6,687 |
| Other Operating Activity | 6,905 | 26,943 | 21,937 | 3,581 | 2,020 |
| Operating Cash Flow | $-12,109 | $-13,122 | $-31,054 | $-20,339 | $-14,638 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -582 | -1,295 | -735 | -2,928 | -1,301 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 13 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 13 | 0 |
| Investing Cash Flow | $-582 | $-1,295 | $-735 | $-2,915 | $-1,301 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -19 | N/A | -54 | 196 | -21 |
| Common Stock Issued | 84 | 39,859 | 39,793 | 308 | 59 |
| Other Financing Activity | -156 | -473 | -203 | -203 | -186 |
| Financing Cash Flow | $-91 | $39,386 | $39,536 | $301 | $-148 |
| Exchange Rate Effect | 57 | 451 | 499 | 556 | 110 |
| Beginning Cash Position | 90,532 | 59,310 | 59,310 | 59,310 | 59,310 |
| End Cash Position | 77,446 | 90,532 | 67,943 | 36,913 | 43,333 |
| Net Cash Flow | $-13,086 | $31,222 | $8,633 | $-22,397 | $-15,977 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,109 | -13,122 | -31,054 | -20,339 | -14,638 |
| Capital Expenditure | -582 | -1,295 | -735 | -2,928 | -1,301 |
| Free Cash Flow | -12,691 | -14,417 | -31,789 | -23,267 | -15,939 |